2022 Nelson's Pediatric Antimicrobial Therapy
by John S. Bradley (Editor)John D. Nelson (Editor)Barnett Elizabeth (Consultant Editor)Joseph B. Cantey (Consultant Editor)David W. Kimberlin (Consultant Editor)Paul E. Palumbo (Consultant Editor)Jason Sauberan (Consultant Editor)J. Howard Smart (Consultant Editor)William J. Steinbach (Consultant Editor)
Format: Paperback
ISBN13: 9781610025645
Paperback|9781610025645
✨ Featured Offer
Used, Very Good
$17.11
List Price: $36.95
🚚
See all 2 offers from $7.06 FREE standard delivery by: 03 Apr 2026
Overview
Completely updated and revised, the 28th edition of this best-selling reference provides instant access to the latest recommendations for treatment of infectious diseases in children.
For each disease, the authors provide a commentary to help select the best of all antimicrobial choices. Drug descriptions cover all antimicrobial agents available today and include complete information about dosing regimens.
TOPICS INCLUDE
For each disease, the authors provide a commentary to help select the best of all antimicrobial choices. Drug descriptions cover all antimicrobial agents available today and include complete information about dosing regimens.
TOPICS INCLUDE
- Antimicrobial Therapy by Clinical Syndromes
- Antimicrobial Therapy for Neonates
- Choosing Among
- Antibiotics
- Antifungal Agents
- Antiviral Agents
- Antiparasitic Agents
- Oral Step-down Therapy for Serious Infections
- Prevention of Symptomatic Infection
- Approach to Antibiotic Allergies
- Antibiotic Stewardship
- Updated recommendations on acute hematogenous osteomyelitis, based on newly published guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America, including information on a decrease in the incidence of MRSA infections, allowing the recommendation of cefazolin, again, in empiric therapy for most pediatric bone infections
- Updated recommendations on influenza treatment and prophylaxis, reflecting American Academy of Pediatrics guidance for 2021-2022
- Ceftazidime/avibactam now preferred over fluoroquinolones for treatment of Klebsiella pneumoniae carbapenemase-producing enteric bacilli, if susceptible
- Cefiderocol, a new iron-binding siderophore cephalosporin class, recently approved in adults for treatment of many drug-resistant pathogens, particularly Acinetobacter, Stenotrophomonas, and Pseudomonas; under study in children
- New dosing for posaconazole suspension formulation
- New approaches to mucormycosis
- Added baloxavir for children 12+ years old
| ISBN-13 | 9781610025645 |
|---|---|
| ISBN-10 | 1610025644 |
| Weight | 0.68 Pounds |
| Dimensions | 4.75 x 0.75 x 6.50 In |
| List Price | $36.95 |
| Edition | 28th Edition |
| Format | Paperback |
|---|---|
| Language | English |
| Pages | 366 pages |
| Publisher | American Academy of Pediatrics |
| Published On | 2022-03-30 |
View All Offers
Sort by:
Price
Condition
Seller
Seller Comments
Price
Used, Good
Seller details
BooksRun
Philadelphia, PA, USA
It's a well-cared-for item that has seen limited use. The item may show minor signs of wear. All the...
Free delivery by: 03 Apr 2026
✨ Used, Very Good
Seller details
HPB-Ruby
Dallas, TX, USA
Connecting readers with great books since 1972! Used books may not include companion materials, and ...
Free delivery by: 03 Apr 2026